Quarterly Results

  • Company Name :
Gufic BioSciences Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 509079
  • NSE Symbol:
  • GUFICBIO
  • P/E(TTM):
  • 50.54
  • ISIN Demat:
  • INE742B01025
  • Div & Yield%:
  • 0.02
  • EPS(TTM):
  • 8.47
  • Book Value(₹):
  • 57.30
  • Market Cap(₹Cr.):
  • 4,292.38
  • Face Value(₹):
  • 1.00
Quarters :  
Particulars September 2024 ( Cr)June 2024 ( Cr)March 2024 ( Cr)
Gross Sales 204.18 202.81 194.99
Excise Duty 0.00 0.00 0.00
Net Sales 204.18 202.81 194.99
Other Operating Income 0.00 0.00 0.00
Other Income 0.11 1.25 0.88
Total Income 204.29 204.07 195.87
Total Expenditure 165.56 167.03 160.77
PBIDT 38.74 37.04 35.11
Interest 5.18 4.62 3.65
PBDT 33.56 32.41 31.46
Depreciation 4.30 4.31 4.34
Tax 7.50 7.00 7.30
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax -0.01 0.25 -0.23
Reported Profit After Tax 21.78 20.86 20.05
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 21.78 20.86 20.05
EPS (Unit Curr.) 2.17 2.08 2.00
EPS (Adj) (Unit Curr.) 2.17 2.08 2.00
Calculated EPS (Unit Curr.) 2.17 2.08 2.00
Calculated EPS (Adj) (Unit Curr.) 2.17 2.08 2.00
Calculated EPS (Ann.) (Unit Curr.) 8.69 8.32 8.00
Calculated EPS (Adj) (Ann.) (Unit Curr.) 8.69 8.32 8.00
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 10.03 10.03 10.03
Reserve & Surplus 0.00 0.00 0.00
Face Value 1.00 1.00 1.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 18.97 18.26 18.01
PBDTM(%) 16.44 15.98 16.13
PATM(%) 10.67 10.29 10.28